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Abstract: Previous research has reported that children with idiopathic short stature (ISS) showed 
functional and cognitive impairments. The purpose of this study was to compare muscle strength 
and body posture between children with ISS treated with growth hormone (GH) and healthy peers 
(healthy children, HC), and to analyze whether these parameters were affected by physical exercise. 
Eighteen children for the ISS group (mean age: 10.96 ± 1.68 years) and 26 children for the HC group 
(mean age: 10.19 ± 1.06 years) were recruited for the study. All participants performed the following 
assessments: handgrip and Sargent test for the muscle strength evaluation; baropodometric and 
stabilometric test for the posturographic measures. Data were analyzed with analysis of covariance 
(ANCOVA) using height and weight as covariate. Groups were then stratified into active and 
inactive and independent t-tests were used to determine differences between variables. Significance 
level was set to p < 0.05. Our results showed a significantly lower performance for both hands (p < 
0.01) and a greater difference of plantar loading distribution between feet in the ISS compared to 
the HC groups (p < 0.01). In relation to physical exercise, the HC active group showed the highest 
handgrip strength values for both hands among the analyzed groups and, moreover, handgrip 
strength of both ISS active and inactive groups was significantly lower than corresponding CH peers 
for both hands. Although ISS and HC inactive groups reported an unequal plantar loading 
distribution between feet (p < 0.05), this asymmetry was not present in both ISS and HC active 
groups. We assume that GH therapy integrated with physical exercise in young patients with ISS 
could be suggested to increase muscle strength and body posture improving their quality of life.  
Keywords: idiopathic short stature; physical activity; muscle strength; body posture; handgrip test; 
Sargent test; GH therapy; GH treatment 
 
1. Introduction 
Idiopathic short stature (ISS) is defined as a disorder of the short stature disturbances group 
characterized by a non-identifiable cause in which children present a height greater than 2 standard 
deviations (SD) below the corresponding mean height for age, gender and population [1,2]. This 
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growth disorder is multifactorial and includes genetic and epigenetic factors, environmental 
conditions and constitutional growth delay [2,3]. The presence of no recognizable cause obtained 
through the diagnostic investigation including medical history, physical examination, laboratory 
tests, and radiological examinations establishes the diagnosis of ISS [2]. Once the diagnosis has been 
ascertained, growth hormone (GH) is widely used for the treatment of ISS even in children with no 
GH insufficiency [4–6]. In order to achieve the maximum possible efficacy of the treatment, clinicians 
manage the therapy differently among patients with ISS, on the basis of several parameters they have 
to take into consideration [7]. Nevertheless, although children treated with growth hormone 
recuperate the height gap, the potential gain of growth rate of the treatment is controversial and, 
anyhow, they may not achieve normal height [4,8,9]. 
Previous research showed both intellectual disorders and psychosocial difficulties as well as 
motor impairments in patients with ISS that negatively influence their quality of life [10]. In 
particular, regarding the intellectual disorders, some studies reported cognitive retardation that 
compromises school performances and social behaviours [2]. Instead, as reported by Cohen et al, the 
psychosocial aspect is affected by the low level of self-esteem that children with ISS could have and 
episodes of bullying to which they could be subject [5]. Furthermore, studies on short stature in 
children have demonstrated the association between this disease and functional limitations as motor 
skills or physical tasks [3,11]. 
As mentioned above, although GH treatment is managed by clinicians mainly for the purpose 
of increasing height in these patients, some research works have investigated the influence of GH 
therapy on various functional and psychological characteristics, as motor skills or cognitive abilities, 
in children with short stature reporting contrasting results [3,12–16]. 
Regarding this issue, physical exercise is known to play a key role in GH release representing an 
effective physiological and non-pharmacological stimulus for the secretion of this hormone [17,18]. 
Some research groups have investigated fitness characteristics in children with short stature, 
however, studies aimed at the influence of physical exercise in features such as muscle strength and 
body posture in these patients are limited [18–21]. Nevertheless, it is widely recognized that physical 
exercise induces to positive effects on both physiological and psychological aspects in children and, 
in general, during the whole lifespan [22–25]. 
For this reason, given the lack of scientific literature on this topic, the aim of the present study 
was to evaluate any differences in characteristics of muscle strength of upper and lower limbs; body 
sway; plantar loading distribution between feet in children with ISS treated with GH hormone 
compared to a healthy age-matched control group. Our hypothesis is that children with ISS could 
show lesser performances of upper and lower limbs strength and poorer level of body balance and 
postural control than healthy peers. Moreover, we hypothesize that physical exercise could improve 
fitness and postural features in children with ISS allowing them to reach equal levels of muscle 
strength and postural control of healthy children. 
2. Materials and Methods 
2.1. Study Design 
In the present observational case-control study, the case group included children with ISS 
treated with GH hormone, while the control group comprised healthy children (HC). ISS group 
subjects were enrolled in the Paediatric and Endocrinology Departments of “ARNAS – G. Di 
Cristina” hospital of Palermo from December 2017 to June 2018, while HC group data were collected 
in several primary schools of the same city from January 2018 to May 2018.  
2.2. Participants 
Eighteen children (10 males and 8 females; mean age: 10.96 ± 1.68 years; mean height: 122.28 ± 
9.61 cm; mean weight: 24.56 ± 4.44 kg; body mass index: 16.41 ± 2.15 kg/m2) for the ISS group and 26 
children (14 males and 12 females; mean age: 10.19 ± 1.06 years; mean height: 140.08 ± 16.29 cm; mean 
weight: 39.36 ± 9.83 kg; body mass index: 19.85 ± 4.2 kg/m2) for the HC group were considered for the 
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study. Participants were excluded from the study whether they met the following exclusion criteria: 
orthopaedic lesions; physical injuries; neurological diseases. Three participants from the ISS group 
were excluded after applying the selection criteria (due to physical injuries and neurological disease: 
n = 2 and n = 1, respectively). Moreover, to discern the influence of physical exercise on the 
aforementioned fitness and postural parameters, for data analysis, both groups were stratified into 
active (i.e., ISS active group vs. HC active group) and inactive (i.e., ISS inactive group vs. HC inactive 
group). Children who were considered physically active had practiced any type of sport/physical 
exercise at least 2 times/week for at least 6 consecutive months from the recruitment time.  
Parents/legal guardians provided a written informed consent which allowed their minors to 
participate in the study from which they could withdraw at any time. The study conforms to the 
Declaration of Helsinki for the use of persons in research and was approved by the Ethical Board of 
the University of Palermo. 
2.3. Maximum Isometric Handgrip Strength Assessment 
Through the handgrip test using a mechanical dynamometer (KernMap model 20K1 — Kern®, 
Kern and Sohn GmbH, Balingen, Germany) each participant performed three trials of 3-second of 
maximum isometric handgrip strength (MIHS), alternatively with the right hand and the left hand, 
separated by 60 seconds of rest period. Before starting assessments, participants familiarized with the 
test and the mechanical dynamometer they would use. Throughout the measurements, each 
participant, sitting on a chair with back resting, head in neutral position and looking forward, were 
given strong verbal encouragement by the researcher to perform the MIHS. All measurements were 
collected by the same researcher. The best recorded MIHS (kg) of the three trials was considered for 
statistical analysis. 
2.4. Explosive-Elastic Lower Limbs’ Strength Assessment 
The explosive-elastic lower limbs’ strength (EELLS) was measured using the Sargent test in 
which each participant performed three trials of maximum high jump separated by 60 seconds of rest 
period. Each participant, maintaining an upright position with the lateral side of the body facing the 
wall and feet side by side, was asked to touch the wall as high as possible with the fingertips of the 
hand closer to the wall. Afterwards, each of them was instructed to bend the knees and to carry out 
the maximum high jump, bringing the arms and the hands upwards, and to touch the wall with the 
fingertips as high as possible. In order to measure the jump height, the same experimenter marked 
with a chalk the exact point on the wall touched by each participant before the jump and that one 
reached during the jump. The difference between the two points was calculated and the best recorded 
value was considered for statistical analysis. 
2.5. Stabilometric and Baropodometric Analysis 
A stabilometric evaluation, in order to quantify body sway, was carried out using the FreeMed® 
posturographic system (Sensor Medica®; Guidonia Montecelio, Rome, Italy) comprising the 
freeMed® Maxi platform and FreeStep® software (version 1.6.007). The stabilometric signal was 
digitized at 50 Hz. The test procedure was the following: each participant was required to stand 
barefoot for 51.2 s in an upright position on the platform, forming a 30° angle with the feet and the 
heels at 3 cm of distance from each other, the arms along the trunk and the head in neutral position 
looking forward [26]. The test was repeated in two different conditions: with eyes open (EO) and eyes 
closed (EC). The posturographic system measured the center of pressure (CoP) displacement and 
calculated the related variables: sway path length (SPL); ellipse surface (ES); speed (S); amplitude of 
antero-posterior sway along the virtual y-axis (∆Y); and amplitude of medial-lateral sway along the 
virtual x-axis (∆X). 
A baropodometric evaluation, in order to measure the percentage of plantar loading distribution 
between feet, was carried out via the same system (FreeMed®; Sensor Medica®; Guidonia 
Montecelio, Rome, Italy). For the assessment, each participant was instructed to maintain an upright 
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position for 5 s barefoot with feet positioned side by side, the arms along the trunk and the head in 
neutral position looking forward. 
2.6. Statistical Analysis 
Means and standard deviations were described for the total sample and for both the ISS and HC 
groups. Strength and posturographic measures were analyzed with analysis of covariance 
(ANCOVA). Each variable was tested across groups using height and weight as covariates. Groups 
were then stratified into active and inactive (i.e., ISS active and HC active groups; ISS inactive and 
HC inactive groups), and independent t-tests were used to determine differences between variables. 
All tests were carried out through jamovi software (version 1.2) [27]. Significance level was set to p < 
0.05. 
3. Results 
Regarding the anthropometric characteristics (Table 1), our results showed significant 
differences between ISS group and HC group both for height (p = 0.001), and weight (p = 0.001) as 
well as BMI (p = 0.003).  
Table 1. Descriptive characteristics of the analyzed groups. 
Characteristics ISS HC p 
Age (years) 10.96 ± 1.68 10.19 ± 1.06 0.068 
Height (cm) 122.28 ± 9.61 140.08 ± 8.14 0.001 * 
Weight (kg) 24.56 ± 4.44 39.36 ± 9.83 0.001 * 
BMI (kg/m2) 16.41 ± 2.15 19.85 ± 4.20 0.003 * 
Data are presented as means ± SD; ISS = idiopathic short stature; HC = healthy control; * = significant. 
Table 2 reported strength performances of upper and lower limbs measured through the 
handgrip test and the Sargent test, respectively. Although the ISS participants had lower performance 
levels compared to those of the HC group, our outcomes showed no significant differences on the 
explosive-elastic lower limbs’ strength (EELLS) between the two groups (p > 0.05). However, 
regarding the handgrip test, the ISS participants showed lower significant values both for the right 
(p = 0.001) and the left (p = 0.004) hand compared to the HC group (Figure 1).  
Table 2. Upper/lower limbs strength performance and posturographic measures of the analyzed 
groups. 
Measures ISS HC p 
Limbs’ strength 
R MIHS (kg) 8.26 ± 2.86 13.07 ± 4.31 0.001 * 
L MIHS (kg) 8.32 ± 3.1 12.03 ± 4.41 0.004 * 
EELLS (cm) 13.33 ± 6.06 15.88 ± 5.78 0.165 
Posturographic measures 
SPL (mm) 229.08 ± 282.54 315.07 ± 298.87 0.343 
ES (mm2) 733.24 ± 313.66 616.66 ± 201.84 0.141 
R Foot load (%) 53.78 ± 8.32 48.42 ± 4.88 0.010 * 
L Foot load (%) 46.22 ± 8.32 51.58 ± 4.88 0.010* 
Data are presented as means ±SD; R = right; L = left; MIHS = maximum isometric handgrip strength; 
EELLS = explosive-elastic lower limbs’ strength; SPL = sway path length; ES = ellipse surface; ISS = 
idiopathic short stature; HC = healthy control; * = significant. 
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Figure 1. Differences in maximum isometric handgrip strength (MIHS) between the ISS and the HC 
groups. Figure highlights a significant difference between groups for both hands. R = Right; L = Left. 
Furthermore, as presented in Table 2, although we did not find any differences in all the 
stabilometric parameters, our findings reported a greater difference of plantar loading distribution 
between feet in ISS compared to the HC group and an opposite plantar loading distribution between 
feet across the analyzed groups (ISS group: 53.78 ± 8.32 % vs. 46.22 ± 8.32 % for the right and the left 
foot, respectively; HC group: 48.42 ± 4.88 % vs. 51.58 ± 4.88 % for the right and the left foot, 
respectively). 
Data analysis in relation to the practice of physical exercise (Table 3) reported that the HC active 
group showed the highest handgrip strength values for both hands among the analyzed groups and, 
moreover, that handgrip strength of ISS active and inactive children was significantly lower than 
corresponding CH peers for both hands (Table 3). Furthermore, ISS and HC inactive groups reported 
an unequal plantar loading distribution between feet (p < 0.05), while this asymmetry was not present 
in both ISS and HC active groups (Table 3).  
Table 3. Upper/lower limbs strength performance and posturographic measures of the groups 
stratified according to physical exercise practice. 
Measures ISS Active HC Active p ISS Inactive HC Inactive p 
Limbs’ strength 
R MIHS (kg) 7.33 ± 2.48 14.03 ± 4.67 0.01 * 8.75 ± 2.92 12.55 ± 4.15 0.01 * 
L MIHS (kg) 7.17 ± 2.59 12.81 ± 4.97 0.02 * 8.94 ± 3.16 11.61 ± 4.19 0.07 
EELLS (cm) 17.43 ± 7.66 20.56 ± 5.25 0.35 12.17 ± 5.67 13.41 ± 4.43 0.51 
Posturographic measures 
SPL (mm) 273.66 ± 432.82 257.07 ± 206.76 0.25 185.78 ± 147.54 345.78 ± 339.56 0.61 
ES (mm2) 831.34 ± 437.48 628.26 ± 239.03 0.92 648.7 ± 208.57 610.53 ± 187.02 0.13 
R Foot load (%) 47.14 ± 7.76 51.22 ± 5.74 0.25 45.42 ± 8.6 51.76 ± 4.55 0.02 * 
L Foot load (%) 52.86 ± 7.76 48.78 ± 5.74 0.25 54.58 ± 8.6 48.24 ± 4.55 0.02 * 
Data are presented as means ± SD; R = right; L = left; MIHS = maximum isometric handgrip strength; 
EELLS = explosive-elastic lower limbs’ strength; SPL = sway path length; ES = ellipse surface; ISS = 
idiopathic short stature; HC = healthy control; * = significant. 
This within-group analysis reported the same asymmetrical loading distribution between feet 
also for the entire two groups of the study (i.e., ISS and HG groups) as shown in Figure 2. 
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Figure 2. Differences between Left (L) and Right (R) plantar loading distribution within the ISS and 
the HC group. The values are stratified for each group between active and inactive participants. 
4. Discussion 
The main purpose of the present study was to evaluate any differences on fitness features such 
as upper and lower limbs strength, postural characteristics such as body sway, and plantar loading 
distribution, between the ISS group and the HC group. Moreover, we analyzed whether there were 
any differences in the aforementioned variables between physically active and inactive children. 
From data analysis, the anthropometric characteristics of the ISS group were significantly lower 
than those of the HC group. These results were expected based on the intrinsic definition of short 
stature (regardless of whether this latter is a primary growth disorder, a secondary growth disorder 
or, as in the sample we recruited, due to an unknown etiology) [2]. In fact, patients with ISS are 
characterized by a height shorter than 2 SD below the normal distribution of the corresponding 
population for age and sex [28,29]. Moreover, as reported by many research groups, children with 
ISS treated with GH therapy, even if this reduced their height gap, may not achieve the peers’ height 
[4,8]. 
Considering our findings, the hypothesis we postulated was partially confirmed. Indeed, we 
found no differences in strength performance of lower limbs and on stabilometric parameters 
between groups. However, the HC group showed higher significant levels of MIHS, for both hands, 
than the ISS group. Furthermore, supporting our hypothesis, when ISS and HC groups were stratified 
into active and inactive, our outcomes reported a symmetrical plantar loading distribution between 
feet for both within-group analyses (i.e., ISS active group and HC active group); whereas both the 
inactive groups of ISS and HC showed an unequal loading distribution between the right and the left 
foot, and this result explains the tendency found for both groups (i.e., ISS and HC). 
Relevant level of limbs’ strength is fundamental in daily life activities and, moreover, represents 
a basic quality possessed by physical activity practitioners and athletes in order to maintain 
physiological body functions and/or enjoy exercise in the best way for the former, and to obtain the 
best possible results for the latter, respectively [30,31]. In particular, handgrip strength has been 
considered as marker of health and some studies have demonstrated the correlation between MIHS 
and global body muscle strength [32,33]. It is widely recognized that a weak handgrip strength can 
affect children's social and psychological spheres causing difficulties in some basic tasks such as 
playing or writing [34]. The handgrip strength results we obtained agree with several studies. In 
particular, since the handgrip test is used for the prognosis of muscle strength in several idiopathic 
and congenital diseases, our results are in agreement with previous results that reported lower 
handgrip strength in patients with various diseases both in adults as well as in children [34,35]. 
However, the main key explanation for the differences we found in the MIHS between the two groups 
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could be the strict correlation existing between handgrip strength and the anthropometric 
characteristics, in particular children’s height, as demonstrated by many research groups [35,36]. 
We suppose that we did not find differences on lower limbs’ strength between ISS and HC 
groups thanks to the effectiveness of the GH treatment to which the children with ISS were subjected, 
according to many previous studies reporting increases in muscle size and muscle strength in 
children treated [37]. 
The physiological function of both the nervous and muscular systems can be altered in ISS 
children with GH hormone deficiency [38,39]. Sartorio et al. have reported that patients with GH 
deficiency show a reduction of the postural and non-postural muscles strength [40]. Musculoskeletal 
abnormalities have been demonstrated to influence negatively body posture [41,42]. Several studies 
have shown poor body balance, abnormalities in postural control and, more generally, impairments 
in motor skills in patients affected by GH hormone deficiency [3,43,44].  
Scientific literature shows many articles have demonstrate that hormonal treatment in children 
improves cognitive and motor abilities reducing the gap with their healthy peers [45]. In the same 
way, Mauras et al. reported higher levels of muscle strength after gonadotropin-releasing hormone 
(GnRHa) treatment in children with short stature [46]. Moreover, several researches demonstrated 
that long-term GH treatment in children with short stature increases muscle mass improving the 
related muscle strength [37,47]. 
These previous researches clearly defined the positive influence of hormone treatment on 
muscle strength in children with short stature. In accordance with what is written above and given 
the effects on several human hallmarks, the promotion of the practice of physical exercise can 
improve muscle strength levels in patients with ISS that are subjected to GH treatment and can 
prevent the aforementioned issues. 
For these reasons, on the basis of our results, we assume that GH therapy integrated with 
physical exercise in young patients with ISS could be suggested, not only to increase muscle strength 
and to improve postural features, but also to stimulate the secretion of GH, improving the general 
quality of life. 
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